Vavricka John Insider Trades

Insider Trading History

Track insider trading activity for Vavricka John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37.1k 8,750 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $348k 82,594 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$49.1k 11,570 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $396k 94,164 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 42,083 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $503k 119,520 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$507k 119,520 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $231k 54,848 shares
Last Trade
Jan 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 33,333 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $219k 52,081 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$35.2k 11,517 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $140k 33,333 shares
Last Trade
Jan 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 33,333 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $559k 132,800 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 150,300 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $90.6k 21,515 shares
Last Trade
Feb 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$45.4k 11,819 shares
$3.84
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $559k 132,800 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$552k 132,800 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $281k 66,666 shares
Last Trade
Jan 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 33,334 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $140k 33,334 shares
Last Trade
Jan 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 33,334 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $589k 140,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$648k 140,000 shares
$4.63
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $568k 135,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$964k 135,000 shares
$7.14
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $494k 117,300 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.56M 117,300 shares
$73.00
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $347k 82,508 shares
Last Trade
Nov 03, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.32M 82,508 shares
$28.15
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Nov 03, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.32M 82,508 shares
$28.15
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$4.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up